» Articles » PMID: 26310265

Ventricular Arrhythmia Storm in the Era of Implantable Cardioverter-defibrillator

Overview
Journal Postgrad Med J
Specialty General Medicine
Date 2015 Aug 28
PMID 26310265
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In the era of widespread use of implantable cardioverter-defibrillators (ICDs) for both primary and secondary prevention of sudden cardiac death, a significant proportion of patients experience episodes of multiple ventricular tachycardia/fibrillation over a short period of time requiring device interventions. The episodes are termed ventricular arrhythmia (VA) or electrical storms. VA storm is a tragic experience for patients, with many psychological consequences. Current management for VA storms remains complex. Acutely, administration of β-blockers, amiodarone and sedation or intubation is generally required to suppress sympathetic tone. Interventional treatment includes catheter ablation and sympathetic blockade by left cardiac sympathetic denervation. Strategies to modify autonomic tone to suppress VAs are the rationale of various novel interventions that have been published in recent studies. All patients with VA storm should be considered for transfer to an experienced high-volume tertiary centre for evaluation and treatment to prevent further recurrence of VA storm.

Citing Articles

Risk factors for electrical storms following percutaneous coronary intervention in patients with acute myocardial infarction: A meta-analysis.

Xiong X, Ye Q, Peng Y Biomol Biomed. 2024; 24(5):1077-1091.

PMID: 38460169 PMC: 11379026. DOI: 10.17305/bb.2024.10274.


Efficacy and safety of catheter ablation as first-line therapy for the management of ventricular tachycardia.

Kotake Y, Huang K, Bennett R, De Silva K, Bhaskaran A, Kanawati J J Interv Card Electrophysiol. 2023; 66(7):1701-1711.

PMID: 36754908 PMC: 10547804. DOI: 10.1007/s10840-023-01483-2.


Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping.

Kotake Y, Nalliah C, Campbell T, Bennett R, Turnbull S, Kumar S J Interv Card Electrophysiol. 2021; 66(1):5-14.

PMID: 34787768 DOI: 10.1007/s10840-021-01088-7.


Amiodarone in the treatment of atrial fibrillation of patients with rheumatic heart disease after valve replacement.

Chen K, Qin L, Lu X, Xia T, Gu Q Pak J Med Sci. 2019; 35(4):918-922.

PMID: 31372117 PMC: 6659075. DOI: 10.12669/pjms.35.4.1298.


An inappropriate pacing threshold increase after repeated electrical storm in a patient with implantable cardioverter defibrillator.

Zhu Y, Gu X, Xu C BMC Cardiovasc Disord. 2017; 17(1):265.

PMID: 29037154 PMC: 5644131. DOI: 10.1186/s12872-017-0695-y.